Drug distributor McKesson Corp raised its annual profit forecast on Wednesday, driven by increased sales in its U.S.
McKesson Corp (MCK) reports a 21% revenue increase and raises fiscal 2025 EPS guidance amid strategic expansions and ...
McKesson Corporation (NYSE: MCK) has released its fiscal 2025 second quarter financial results. Results can be accessed on McKesson’s Investor Relatio ...
McKesson Medical-Surgical Inc. entered into an agreement with the Labor Department on Monday resolving employment ...
Elizabeth Warren seeks scrutiny of deals that would allow drug middlemen McKesson, Cardinal Health, and Cencora to also ...
Following Donald Trump's election night victory, many publicly traded businesses in Dallas-Fort Worth saw a rise in stock ...
Chicago Partners Investment Group LLC increased its stake in shares of McKesson Co. (NYSE:MCK – Free Report) by 17.0% during ...
Operator Good evening, and welcome to MercadoLibre's Q3 2024 conference call. [Operator instructions] Please note this event is being recorded. I would now like to turn the conference over to Richard ...